Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised.

Cheta DM, Lim J, Chan EK, Kunakorn T, Charles MA.

Life Sci. 1995;57(24):2281-90.

PMID:
7475982
2.

Glipizide-induced prevention of diabetes and autoimmune events in the BB rat.

Hosszufalusi N, Reinherz L, Takei S, Chan E, Charles MA.

J Autoimmun. 1994 Dec;7(6):753-61.

PMID:
7888033
3.

The effects of nicotinamide and glimepiride on diabetes prevention in BB rats.

Pan J, Chan EK, Cheta D, Schranz V, Charles MA.

Life Sci. 1995;57(16):1525-32.

PMID:
7564897
4.
6.

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID:
16861090
7.

Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial.

Derosa G, Gaddi AV, Piccinni MN, Salvadeo S, Ciccarelli L, Fogari E, Ghelfi M, Ferrari I, Cicero AF.

Diabetes Obes Metab. 2006 Mar;8(2):197-205.

PMID:
16448524
8.
9.

Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.

Buschard K, Pedersen C, Hansen SV, Hageman I, Aaen K, Bendtzen K.

Autoimmunity. 1992;14(2):101-4.

PMID:
1303676
10.

Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.

van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.

Diabet Med. 1997 Jul;14(7):556-63.

PMID:
9223393
12.

Prevention of diabetes in BB/Wor rats by intrathymic islet injection.

Koevary SB, Blomberg M.

J Clin Invest. 1992 Feb;89(2):512-6.

13.

Prophylactic insulin treatment of syngeneically transplanted pre-diabetic BB-DP rats.

Sparre T, Sprinkel AM, Christensen UB, Karlsen AE, Pociot F, Nerup J.

Autoimmunity. 2003 Mar;36(2):99-109.

PMID:
12820692
14.

Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.

Derosa G, Gaddi AV, Piccinni MN, Ciccarelli L, Salvadeo S, Peros E, Ghelfi M, Ferrari I, Cicero AF.

Pharmacotherapy. 2005 May;25(5):637-45.

PMID:
15899724
15.

The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat.

Tobia MH, Zdanowicz MM, Wingertzahn MA, McHeffey-Atkinson B, Slonim AE, Wapnir RA.

Mol Genet Metab. 1998 Mar;63(3):205-13.

PMID:
9608543
16.

Syngeneic islet transplantation in prediabetic BB-DP rats--a synchronized model for studying beta-cell destruction during the development of IDDM.

Christensen UB, Sparre T, Cooke A, Andersen HU, Mandrup-Poulsen T, Nerup J.

Autoimmunity. 1998;28(2):91-107.

PMID:
9771979
17.

Prevention and cure of type 1 diabetes in the BB rat by islet allotransplantation and glimepiride treatment.

Pan J, Chan EK, Yu E, Chen J, Schranz V, Charles MA.

Transplant Proc. 1995 Dec;27(6):3194. No abstract available.

PMID:
8539908
18.

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

Rosenstock J, Samols E, Muchmore DB, Schneider J.

Diabetes Care. 1996 Nov;19(11):1194-9.

PMID:
8908379
19.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411

Supplemental Content

Support Center